Medicare drug price negotiations: A game-changer for seniors’ healthcare
By
Luka Yancopoulos
Nov 02, 2023
The relatively recent passage of the Inflation Reduction Act, which among other provisions, allows Medicare to negotiate prescription drug prices, marks a monumental shift in senior healthcare in America.
COVID-19 meds like Paxlovid will soon have big price tags
Oct 30, 2023
The pills still will be available at no cost until those bought earlier by the federal government run out.
Amazon Pharmacy expands drone delivery service to prescription medications
By
Kimberly Bonvissuto
Oct 20, 2023
Older adults in one Texas town looking to simplify their medication management might be able to have prescriptions delivered via drone.
FDA adds warning to Ozempic label about risk for blocked intestines
Sep 27, 2023
The side effect (ileus) also is listed on labels for the weight-loss drug Wegovy and the diabetes medication Mounjaro.
Diabetes drug maker sues over compounded versions of Mounjaro
Sep 20, 2023
The lawsuits are meant to stop the other companies from “the unlawful marketing and sale of non-FDA approved compounded products.”
Med-management software company releases new tool for nursing facilities to meet new need for CMS compliance
By
Aaron Dorman
Sep 20, 2023
To meet new CMS rules for nursing homes, one company is releasing a new service that focuses on ensuring a patient’s medication listings are up-to-date.
Being in good shape tied to fewer mental health Rx
Sep 11, 2023
There was not an association noted between a reduced risk for medication use for adults aged 65 or more years.
AI could make implantable drug delivery a realistic option for many seniors, research suggests
By
Aaron Dorman
Sep 08, 2023
Researchers have proposed an implantable drug delivery system that uses AI to help avoid buildup of scar tissue or autoimmune responses.
Telehealth giants pairing obesity drugs with weight-loss programs to prevent overreliance on prescriptions
By
Aaron Dorman
Aug 23, 2023
Telehealth companies could offer, or even require, virtual fitness program pairing with obesity drugs, as new procedures are developed.
Eligibility limited for anti-β amyloid mAbs in seniors with MCI
Aug 18, 2023
Few older adults with mild cognitive impairment or mild dementia were eligible for lecanemab or aducanumab after applying clinical trial criteria.